ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,060Medicare Part D Prescriptions Filled, Including Refills

Rank: 192 out of 1206

$487K Total Retail Price of All Prescriptions

Rank: 176 out of 1206

425 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,449 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
HYDROCODONE-ACETAMINOPHEN 383 334 S3 1 7
POTASSIUM CHLORIDE 362 313 2 12
OMEPRAZOLE 344 272 3 3
LEVOTHYROXINE SODIUM 338 278 4 2
FUROSEMIDE 334 298 5 5
LISINOPRIL 298 293 6 4
WARFARIN SODIUM 293 276 7 8
SIMVASTATIN 265 214 8 1
CITALOPRAM HBR 220 187 9 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 153 10 27
METFORMIN HCL 166 141 11 10
POLYETHYLENE GLYCOL 3350 160 140 12 31
ATENOLOL 159 140 13 14
AMITRIPTYLINE HCL 156 126 R 14 59
RANITIDINE HCL 153 130 15 23
PREDNISONE 150 114 16 28
METOPROLOL SUCCINATE 145 142 17 15
DIGOXIN 144 143 18 43
AMLODIPINE BESYLATE 137 137 19 6
FENTANYL 131 120 S2 20 51
METOPROLOL TARTRATE 128 110 21 9
ATORVASTATIN CALCIUM 125 108 22 13
SERTRALINE HCL 118 93 23 22
TRIAMCINOLONE ACETONIDE 116 85 24 102
FLUOXETINE HCL 112 71 25 52
CLOPIDOGREL 111 104 26 48
GABAPENTIN 106 66 27 18
ISOSORBIDE MONONITRATE ER 104 97 28 40
PRENATAL PLUS 103 95 29 287
CLOTRIMAZOLE 95 35 30 262
CARVEDILOL 88 77 31 32
MIRTAZAPINE 86 86 32 50
TRIAMTERENE-HCTZ 82 82 33 33
NEXIUM 79 50 34 47
SPIRONOLACTONE 78 71 35 41
TORSEMIDE 76 53 36 144
LOVASTATIN 76 76 36 44
LEVOFLOXACIN 76 58 36 78
TRAMADOL HCL 72 59 39 17
QUETIAPINE FUMARATE 71 70 40 79
PLAVIX 68 67 41 72
DIOVAN 65 65 42 57
LANTUS 64 56 43 38
ALENDRONATE SODIUM 63 63 44 19
DICLOFENAC SODIUM 63 48 44 104
TAMSULOSIN HCL 61 61 46 26
PRAVASTATIN SODIUM 59 48 47 21
HYDROCHLOROTHIAZIDE 58 52 48 11
LANTUS SOLOSTAR 58 44 48 85
ADVAIR DISKUS 51 51 50 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.